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Background: Hyperactivation of microglia is considered to be a key hallmark of brain inflammation and plays a
critical role in regulating neuroinflammatory events. Neuroinflammatory responses in microglia represent one of the
major risk factors for various neurodegenerative diseases. One of the strategies to protect the brain and slow down
the progression of these neurodegenerative diseases is by consuming diet enriched in anti-oxidants and polyphenols.
Therefore, the present study aimed to evaluate the anti-inflammatory effects of rice bran extract (RBE), one of the rich
sources of vitamin E forms (tocopherols and tocotrienols) and gamma-oryzanols, in primary rat microglia.
Methods: The vitamin E profile of the RBE was quantified by high-performance liquid chromatography (HPLC).
Microglia were stimulated with lipopolysaccharide (LPS) in the presence or absence of RBE. Release of prostaglandins
(prostaglandin (PG) E2, 8-iso-prostaglandin F2α (8-iso-PGF2α)) were determined with enzyme immunoassay (EIA). Protein
levels and genes related to PGE2 synthesis (Cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1
(mPGES-1)) and various pro- and anti-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-10), were assessed by
western blot, ELISA, and quantitative real-time PCR. Furthermore, to elucidate the molecular targets of RBE, the
phosphorylated state of various mitogen-activated protein kinase (MAPK) signaling molecules (p38 MAPK, ERK 1/2, and
JNK) and activation of NF-kB pathway was studied.
Results: RBE significantly inhibited the release of PGE2 and free radical formation (8-iso-PGF2α) in LPS-activated primary
microglia. Inhibition of PGE2 by RBE was dependent on reduced COX-2 and mPGES-1 immunoreactivity in microglia.
Interestingly, treatment of activated microglia with RBE further enhanced the gene expression of the microglial M2
marker IL-10 and reduced the expression of pro-inflammatory M1 markers (TNF-α, IL-1β). Further mechanistic studies
showed that RBE inhibits microglial activation by interfering with important steps of MAPK signaling pathway.
Additionally, microglia activation with LPS leads to IkB-α degradation which was not affected by the pre-treatment
of RBE.
Conclusions: Taken together, our data demonstrate that RBE is able to affect microglial activation by interfering in
important inflammatory pathway. These in vitro findings further demonstrate the potential value of RBE as a
nutraceutical for the prevention of microglial dysfunction related to neuroinflammatory diseases, including
Alzheimer’s disease.
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Neuroinflammation is one of the critical events in the pro-
gression of various neurodegenerative disorders such as
multiple sclerosis (MS), Parkinson’s disease (PD), amyo-
trophic lateral sclerosis (ALS), and Alzheimer’s disease
(AD) [1–4]. The main cell types responsible for the en-
hanced inflammation in various CNS pathologies are glial
cells. Among them, activated microglia are principally in-
volved in the maintenance and progression of neuroin-
flammation [5]. Microglia are resident immune cells in
CNS and regarded as the primary component of the brain
immune system. Under physiological conditions, these
cells are constantly engaged in scanning their microenvir-
onment for any exogenous or endogenous signals in ef-
forts to maintain the homeostasis [6]. Infection, traumatic
injury, ischemia, neurodegenerative diseases, or any al-
tered neuronal activity indicating a potential threat to
CNS can evoke profound changes in the microglial
morphology and function [5, 7–9]. Under activated state,
microglia is known to release a variety of cytotoxic media-
tors such as reactive oxygen species (ROS), pro-
inflammatory cytokines, adenosine triphosphate (ATP),
and arachidonic acid (AA) derivatives [10–13]. These
over-released mediators further exert their toxic effects on
the healthy neurons and result in a vicious and self-
propagating cycle of neuronal death [14]. Therefore,
microglial activation-associated inflammation serves as an
important model for investigating potential therapeutic
entities for slowing the progression of neuronal cell death
in neurodegenerative disorders.
Prostaglandin E2 (PGE2) is AA derivative, the produc-
tion of which is catalyzed by the cyclooxygenases and
prostaglandin (PG) E synthases (PGESs) enzymes.
Cyclooxygenases exist in two subtypes, cyclooxygenase-
1 (COX-1) and cyclooxygenase-2 (COX-2). COX-2 has
been shown to be overexpressed by bacterial cell wall
component lipopolysaccharide (LPS) in cultured micro-
glia [15]. The final step in the synthesis of PGE2 is reg-
ulated by PGESs. To date, three PGESs have been
characterized: the microsomal PGESs (microsomal
prostaglandin E synthase-1 (mPGES-1) and mPGES-2)
and the cytosolic PGES (cPGES) [16, 17]. Among these,
mPGES-1 is an inducible enzyme, and it has been
shown to be upregulated in activated microglia [18].
These enzymes are regulated by a variety of intracellu-
lar signaling molecules such as nuclear factor-kappa B
(NF-kB) and mitogen-activated protein kinases
(MAPK). NF-kB is a transcription factor, and it has
been shown to be a central regulator of inflammatory
response. MAPKs are a family of serine/threonine pro-
tein kinases which are critical for the production of in-
flammatory mediators. Some of the main kinases in
this group include extracellular signal-regulated kinases
(ERK 1/2), c-Jun N-terminal kinase (JNK) and p38isoforms. In particular, increased activity of p38 MAPK
has been closely associated with pathologies involved in
neurodegenerative diseases [19]. Several studies have
demonstrated that p38 MAPK is upregulated during
microglial inflammation [20]. Evidence suggests that
patients with neurodegenerative diseases such as AD
might benefit from p38 MAPK inhibitors [21]. There-
fore, there is a need to develop compounds which can
interfere with the activities of these kinases, hence
modulate age related as well as activated microglia-
associated neuroinflammatory diseases.
Recently, it has been revealed that natural compo-
nents, plant extracts, and polyunsaturated fatty acids are
useful for the prevention of neurodegenerative diseases
[22, 23]. Extracts containing polyphenols and vitamin E
have shown to confer neuroprotection in animal models
[24, 25]. One of such extracts containing these compo-
nents is rice bran extract (RBE). Rice bran is obtained as
a by-product in the rice milling process, a method in
which the outer layer of rice grain is removed. Rice bran
and its ingredients have been shown to impart a number
of health-promoting functions. These functions include
cholesterol-lowering, prevention of ulcer formation,
anti-oxidant, anti-inflammatory, anti-diabetic, and im-
munomodulatory effects [26–29]. The main components
of rice bran are tocotrienols, tocopherols, and oryzanols
(a mixture of ferulic acid esters of triterpene alcohol and
phytosterols) [30]. In comparison with pure rice bran
(which gets quickly rancid, leaving bran inedible), the
above mentioned components are enriched with stabi-
lized Egyptian rice bran extract. The recent studies are
showing the beneficial effects of stabilized Egyptian RBE
in aging- and dementia-associated disease models. For
instance, Hagl et al. reported that the oral consumption
of RBE for 3 weeks improved aging-related mitochon-
drial dysfunction in 18-month-old Naval Medical Re-
search Institute mice (NMRI) [31]. In an another
attempt, authors showed that RBE compensates mito-
chondrial dysfunction in an in vitro model of early AD
[32]. More recently, RBE-supplemented diet showed its
potential in decreasing inflammation associated to meta-
bolic disorders [33]. To date, it is not established
whether RBE interferes in microglial activation, a critical
event in inflammation-associated neurodegenerative dis-
eases. Consequently, we have investigated the effects of
RBE in LPS-activated primary rat microglia.
Methods
All experiments and animal procedures were performed
according to the guidelines of ethics committee of
University of Freiburg Medical School under approved
protocol (Nr. X-13/06A). Animals were obtained from
Center for Experimental Models and Transgenic
Services-Freiburg (CEMT-FR). Maximum efforts were
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suffering during this study.
Chemicals
Heat-stabilized Egyptian rice bran extract was kindly pro-
vided by Dr. Amr Helal from IT&M S.A. (Giza, Egypt).
After overnight maceration in ethanol, three successive ex-
traction sessions under reflux at 40 °C were applied. The
extraction ratio was 3:1. The extract was evaporated under
vacuum at a temperature not exceeding 50 °C. The vitamin
E profile of the RBE was quantified by HPLC, described
elsewhere [30, 34] and as follows (all values in μg/g): alpha-
tocopherol, 86; beta-tocopherol, 71; gamma-tocopherol,
288; delta-tocopherol, 93; alpha-tocotrienol, 55; beta-
tocotrienol, not detectable; gamma-tocotrienol, 2226; and
delta-tocotrienol, 266. LPS from Salmonella typhimurium
(Sigma Aldrich, Deissenhofen, Germany) was resuspended
in sterile phosphate-buffered saline (PBS, 5 mg/ml) as
stock, subsequently used at a final concentration
(10 ng/ml) in the cultures. The (±)-α-tocopherol
(Sigma Aldrich, Deissenhofen, Germany) was dissolved
in ethanol as 100 mM stock solution. Recombinant
macrophage-colony stimulating factor (M-CSF) was
used at 50 ng/ml as final concentration (Thermo Fisher
Scientific, Darmstadt, Germany).
Primary microglia cultures
Primary mixed glial cell cultures were established from
cerebral cortices of 1-day neonatal Sprague–Dawley rats
as described in our previous studies [35]. In brief, brains
were carefully taken. Cerebral cortices were collected
and freed from meninges. Forebrains were then minced
and gently dissociated by repeated pipetting in Dulbecco’s
modified Eagle’s medium (DMEM) and filtered by passing
through 70-μm nylon cell strainer (BD biosciences,
Heidelberg, Germany). Cells were collected by centrifu-
gation (1000g, 10 min) and resuspended in DMEM
containing 10 % fetal calf serum (FCS) (GE Healthcare,
Germany) and antibiotics 1 % penicillin and strepto-
mycin (40 U/ml and 40 μg/ml, respectively) (Sigma
Aldrich, Germany). Cells were then cultured on 10-cm
cell culture dishes (Falcon, Heidelberg, Germany) with
the density of 5 × 105 cells/ml in 5 % CO2 at 37 °C.
After 12–14 days in vitro, floating microglia were har-
vested from mixed glia (astrocyte-microglia) cultures
and re-seeded into cell culture plates at the density of
either 2 × 105 cells/well or 1.2 × 106 cells/dish. On the
next day, medium was removed to get rid of non-
adherent cells and fresh medium was added. After 1 h,
the cells were stimulated for respective experiments.
Cell viability assay
Viability of primary rat microglia after treatment with
RBE was measured by the CellTiter-Glo® LuminescentCell Viability Assay (Promega). This assay is used to de-
termine the number of metabolically active and viable
cells, based on the quantitation of ATP present in the
cells. Cells (2 × 105/ml) were cultured for 24 h, subse-
quently incubated with RBE (10–300 μg/ml) for 24 h.
Thereafter, the cells were treated with or without LPS
(10 ng/ml) for the next 24 h. RBE was dissolved in etha-
nol and ethanol was used in the control wells (at final
conc. of 0.15 %) during experiments. After 48 h of incu-
bation, the concentration of ATP was measured after
adding 100 μl of reconstituted substrate (for 10 min).
Thereafter, luminescence was measured in GloMax®
Luminometer (Promega).
Determination of PGE2 and 8-iso-PGF2α production from
LPS-activated microglia
Cultured primary rat microglia were incubated with ei-
ther RBE (10–300 μg/ml) or with α-tocopherol (10–
100 μM) for 24 h. Afterwards, the cells were treated with
or without LPS (10 ng/mL) for the next 24 h. After the
end of the incubation period, supernatants were col-
lected and centrifuged at 1000g for 5 min at 4 °C. PGE2
and 8-iso-prostaglandin F2α (8-iso-PGF2α) production
was assessed in cell supernatants with a commercially
available enzyme immunoassay (EIA) kit (Biotrend,
Cologne, Germany, and Cayman Chemicals, Ann Arbor,
Michigan, USA) respectively, followed by measurement
at 450 nm according to manufacturer’s instructions. For
PGE2, standards from 39 to 2500 pg/ml were used and
sensitivity of the assay was 36.2 pg/ml. The 8-iso-PGF2α
assay has a range of standards from 0.5 to 500 pg/ml
and sensitivity approximately of 3 pg/ml.
Determination of TNF-α, IL-1, and IL-6 release in microglia
Effects of RBE and α-tocopherol were also studied
by determining the release of various cytokines.
Briefly, microglia were pre-incubated either with RBE
(50–300 μg/ml) or with α-tocopherol (10–100 μM).
Afterwards, LPS (10 ng/ml) was added for 24 h, and
release of tumor necrosis factor (TNF)-α and IL-6
was determined in the cell supernatants which were
collected after centrifugation at 1000g for 5 min at
4 °C. For the release of IL-1β at the end of the incu-
bation, ATP (1 mM) was added for 30 min in all the
wells followed by the collection of cell supernatants.
Addition of ATP was important since maturation
and release of IL-1β is dependent on the IL-1β converting
enzyme (ICE)/caspase 1. For determination of TNF-α
(eBioscience, Frankfurt, Germany), IL-6 (Thermo Fisher
Scientific, Darmstadt, Germany) and IL-1β (R&D Systems
Europe, Ltd., Abingdon, UK), commercially available
ELISA kits were used. All the measurements were done at
450 nm according to the manufacturer’s instructions. For
TNF-α, standards from 16 to 2000 pg/ml were used with
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1500 pg⁄ml with sensitivity <5 pg/ml, and IL-1β
standards were between 31.5 and 2000 pg/ml with
sensitivity of <5 pg/ml.
Immunoblotting
Rat primary microglia were left treated with RBE
(50–300 μg/ml) for 24 h; then, the LPS (10 ng/mL) was
added for different time points (depending on the studied
protein). After the experiment, the cells were washed with
cold PBS and lysed in the lysis buffer (42 mM Tris–HCl,
1.3 % sodium dodecyl sulfate, 6.5 % glycerin, 100 μM so-
dium orthovanadate, and 2 % phosphatase and protease
inhibitors). Protein concentration of the samples was mea-
sured using the bicinchoninic acid (BCA) protein assay kit
(Thermo Fisher Scientific, Bonn, Germany) according to
the manufacturer’s instructions. For western blotting,
10–20 μg of total protein from each sample was subjected
to sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis (SDS-PAGE) under reducing conditions. Afterward,
proteins were transferred onto polyvinylidene fluoride
(PVDF) membranes (Millipore, Germany). After blocking
with 5 % milk solution (BioRad, Munich, Germany) in
Tris-buffered saline (TBS) containing 0.1 % Tween 20
(TBS-T), membranes were incubated with primary anti-
bodies. Primary antibodies used were goat anti-COX-2
(1:500; Santa Cruz Biotechnology, Heidelberg, Germany),
rabbit anti-mPGES-1 (1:6000; Agrisera, Vännas, Sweden),
anti-inhibitor of kB (IkB)-α (1:500; Santa Cruz Biotechnol-
ogy), anti-p44/42 (1:1000; Cell Signaling Technology,
Frankfurt, Germany), anti-p38 (1:1000; Cell Signaling
Technology), anti-JNK (1:1000; Cell Signaling Technol-
ogy), anti-phospho p44/42 (1:1000; Cell Signaling Tech-
nology), anti-phospho-p38 (1:1000; Cell Signaling
Technology), anti-phospho-JNK (1:1000; Cell Signaling
Technology), and rabbit anti-actin (1:5000; Sigma
Aldrich). Primary antibodies were diluted in TBS-T and
5 % BSA. Membranes were incubated with the primary
antibody overnight at 4 °C followed by incubation in sec-
ondary antibodies. After extensive washing (three times
for 10 min each in TBS containing 0.1 % Tween 20), pro-
teins were detected with either horseradish peroxidase
(HRP)-coupled anti-goat IgG (Santa Cruz Biotechnology)
or anti-rabbit IgG (R&D systems, Wiesbaden-
Nordenstadt, Germany) using enhanced chemilumines-
cence (ECL) reagents (GE Healthcare, Freiburg, Germany).
Densitometric analysis was performed using ImageJ soft-
ware (NIH, USA), and a β-actin control was used to con-
firm equal sample loading and normalization of the data.
Real-time quantitative PCR
Quantitative real-time PCR (qPCR) was performed to
determine the transcriptional regulation of COX-2,
mPGES-1, TNF-α, IL-1β, IL-6, and IL-10 by RBE inactivated microglia. RNA preparation was done by using
RNAspin mini RNA isolation kit (GE Healthcare,
Freiburg, Germany) and for cDNA synthesis, 1 μg of
total RNA was reverse transcribed using M-MLV reverse
transcriptase and random hexamers (Biomers, Ulm,
Germany). The synthesized cDNA was the template for
the real-time PCR amplification that was carried out by
the CFX96 real-time PCR detection system (Bio-Rad
Laboratories, Inc.) using iQTM SYBRTM Green supermix
(Bio-Rad Laboratories GmbH, Munich, Germany).
Specific primers were designed by using Universal Probe
Library Assay Design Center (Roche) and were obtained
from Biomers (Ulm, Germany). Reaction conditions were
3 min at 95 °C, followed by 40 cycles of 15 s at 95 °C, 30 s
at 50 °C, and 45 s at 72 °C, and every cycle was followed
by plate reading. After that, 1 min at 95 °C, 1 min at
55 °C, followed by melt curve conditions of 65 °C, 95 °C
with increment of 0.5C for 5 s, followed by final plate
reading. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) served as an internal control for sample
normalization, and the comparative cycle threshold Ct
method was used for data quantification as described
previously [36]. The following primer sequences were used
in the present study. COX-2: Fwd 5′-GGCTTACAA
GACGCCACATCACCT-3′; Rev 5′-TGGTTTAGGCGG
CCGGGGAT-3′; mPGES-1: Fwd 5′-AGGCCAAGTCA
GGCTGCGGA-3′; Rev 5′-GTCGTTGCGGTGGGCTC
TGAG-3′; TNF-α: Fwd 5′-CCCACGTCGTAGCAAAC
CACCA-3′; Rev 5′-CCATTGGCCAGGAGGGCGTTG-
3′; IL-1β: Fwd 5′-TGTGATGAAAGACGGCACAC-3′;
Rev 5′-CTTCTTCTTTGGGTATTGTTTGG-3′; IL-6:
Fwd 5′-CCTGGAGTTTGTGAAGAACAACT-3′; Rev 5′-
GGAAGTTGGGGTAGGAAGGA-3′; IL-10: Fwd 5′-AGT
GGAGCAGGTGAAGAATGA-3′; Rev 5′-TCATGGCCT




Microglial cells were pre-incubated with RBE (50–
300 μg/ml) for 24 h; thereafter, LPS (10 ng/ml) was
added for the next 24 h. Flow cytometry-based cell
cycle analysis was performed as previously described
with few modifications [37]. After the end of the incu-
bation period, the media was removed and cells were
washed with warm PBS. Subsequently, cells were de-
tached from the culture dishes using 0.05 % trypsin
(incubated at 37 °C, 5 min) and were then suspended
in medium containing 10 % FCS. Afterwards, the cells
were centrifuged (1000 rpm, 5 min) and the pellet was
suspended in PBS and fixed overnight with 70 % etha-
nol. The next day, permeabilization (0.05 % Triton X-
100) and staining with propidium iodide (PI, 50 μg/ml;
0.1 mg/ml RNaseA in PBS) was performed by
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stained cells were centrifuged (at 1500 rpm for 5 min)
and pellet was suspended in 500 μl of PBS for flow
analysis. The DNA content was then quantified using
a FACScaliburTM flow cytometer (BD Biosciences,
San Jose, CA, USA) equipped with argon laser
(488 nm). While running the cytometer, dot plots were
displayed to identify the cells based on their physical
parameters on the forward scatter light (FSC) vs. side
scatter light (SSC). To evaluate cell cycle progression,
samples were acquired with the FL-2 fluorescence
channel set to a linear scale, which allows better
characterization of the G0/G1 and G2/M DNA peaks.
Pulse processing was used to exclude cell doublets and
clumps from the analysis. This can be achieved by
using pulse area vs. pulse width. For the analysis, a
gate was set on the single cell population using pulse
width vs. pulse area. Then, this gate was applied to the
scatter plot to gate out obvious debris. Thereafter,
gates were combined and applied to the PI histogram
plot. To quantitate the percentage of cells in each cell
cycle phase, markers were set within the analysis
program.
Statistical analysis
Statistical analyses were performed using Prism 5 soft-
ware (GraphPad software Inc., San Diego, CA, USA).
Values of all experiments were represented as mean ±
SEM of at least three independent experiments. Raw
values were converted to percentage and LPS (10 ng/ml)
was considered as 100 %. Values were compared using
one-way ANOVA with post hoc Student-Newman-Keuls
test (multiple comparisons). The level of significance
was set at *p < 0.05, **p < 0.01, and ***p < 0.001.
Results
RBE significantly reduced the LPS-induced PGE2 release
without any detrimental effects on the viability of cells
To investigate whether RBE exerts anti-inflammatory
effects, microglia cells were pre-incubated with RBE
(10–300 μg/ml) for 24 h and then stimulated with or
without LPS (10 ng/ml) for the next 24 h. As a result,
we observed a marked increase in the production of
PGE2 in the supernatants of microglia cells stimulated
with LPS (6831 ± 799.0 pg/ml, p < 0.001) as compared
to unstimulated cells (78.27 ± 24.27 pg/ml). Treatment
with RBE for 24 h prior to stimulation with LPS resulted
in a significant decrease in the release of PGE2 when com-
pared with LPS (considered as 100 %). Significantly re-
duced levels of PGE2 were evident starting from the
concentration of 25 μg/ml RBE (61.97 ± 1.70 %, p < 0.05),
and a maximal decrease was observed at the concentra-
tion of 300 μg/ml (15.57 ± 5.90, p < 0.001) as shown in
Fig. 1a. To rule out whether these effects were due to thedecrease in the cell viability, ATP cell viability assay was
performed. Obtained data showed that all the concentra-
tions (ranging from 10 to 300 μg/ml) had no adverse ef-
fects on ATP levels and thus viability of the microglial
cells. Control cells incubated with ethanol (used as solvent
for RBE) at the end concentration of 0.15 % had no ad-
verse effects on the viability. This conveys that reduction
in the levels of PGE2 by RBE was not due to the cytotox-
icity. More interestingly, the concentrations ranging from
50 to 300 μg/ml further elevated the levels of ATP in acti-
vated microglia as depicted in Fig. 1b. In addition, RBE
(300 μg/ml) itself significantly increased the ATP levels
under basal conditions (non-activated). Given the pro-
proliferative function of vitamin E congeners [38], we sus-
pected that increased levels of ATP by RBE might be due
to its interference in the microglial cell cycle, increasing
DNA content, hence affecting the viability of cells. There-
fore, we performed cell cycle analysis by using DNA dye-
propidium iodide (see Additional file 1: Figure S1(A-K)).
As a result, we observed a tendency towards the en-
hancement of S and G2/M phases after 48-h incuba-
tion of RBE (300 μg/ml) in comparison with the
control cells but, it did not reach to a statistical sig-
nificant value (Additional file 1: Figure S1(K)). Since
there was a further enhancement of ATP levels with
RBE (threshold concentration of 50 μg/ml) in LPS-
activated microglia (see Fig. 1b), we also performed
assays with RBE (50–300 μg/ml) in activated microglia.
Consequently, a trend (between RBE 100–300 μg/ml)
towards an increase in percentage of cells in S and G2/M
phases has seen as compare with LPS (10 ng/ml),
indicating a minor enhancement of cell proliferation.RBE inhibits the free radical formation in LPS-induced rat
microglia
Given the anti-oxidant properties of RBE [39], we also
speculated that RBE might exert its anti-oxidative effects
in activated microglia. To this end, we studied the effects
of RBE on the formation of free radical formation in
LPS-activated microglia. Measurement of 8-iso-PGF2α
release is taken as a sensitive marker to assess free rad-
ical formation [40], and we have previously shown that
LPS significantly increases the levels of 8-iso-PGF2α in
primary microglia [41]. Indeed, here, we also observed
that LPS (10 ng/ml) significantly enhanced the levels of
8-iso-PGF2α (134.8 ± 12.08 pg/ml, p < 0.001) as com-
pared to basal levels (44.15 ± 15.80 pg/ml). Pre-
incubation of RBE for 24 h reduced the levels of released
8-iso-PGF2α in LPS-activated microglia. This reduction
in the levels was achieved ranging from the concentra-
tion of RBE 100 μg/ml (53.73 ± 6.57 %, p < 0.05), RBE
200 μg/ml (44.97 ± 6.76 %, p < 0.05), and 300 μg/ml
(49.16 ± 8.54 %, p < 0.05). RBE did not show any effect in
Fig. 1 a Rice bran extract (RBE) inhibits the release of prostaglandin E2 (PGE2) in lipopolysaccharide (LPS)-activated microglia. b RBE did not exert
any adverse effects on viability in LPS-stimulated microglia cells. Microglia were pre-treated with RBE (10–300 μg/ml) for 24 h; afterwards, cells
were activated with or without LPS (10 ng/ml) for the next 24 h. At the end of incubation, cell supernatants were collected and release of PGE2
(a) was measured by enzyme immune assay (EIA). ATP assay was performed to assess the microglia cell viability after RBE (10–300 μg/ml) treatment in the
absence or presence of LPS (10 ng/ml). For a detailed measurement protocol, see the “Methods” section. Statistical analyses were carried out by using
one-way ANOVA with post hoc Student-Newman-Keuls test (multiple comparisons). Results are expressed as means ± SEM of at three
independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 compared with LPS (10 ng/ml)-activated cells; #p < 0.001 compared with
control cells
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(Fig. 2).
RBE supresses the PGE2 production by inhibiting the
COX-2 and mPGES-1 expressions in LPS-activated
microglia
PGE2 is synthesized during microglia activation through
the enzymatic action of COX-2 and mPGES-1. It is
known that mPGES-1 is coupled with COX-2 in the bio-
synthesis of PGE2. Consequently, we determined
whether the effect of RBE on PGE2 was mediated
through an inhibition of the synthesis of these enzymes.As shown in Fig. 3a, RBE (50 μg/ml) did not cause a sig-
nificant reduction in COX-2 protein expression in acti-
vated (LPS 10 ng/ml) microglia. However, significant
reduction in COX-2 immunoreactivity was observed ini-
tially at 100 μg/ml and was strongly inhibited at 200 and
300 μg/ml. On the contrary, inhibition of mPGES-1 pro-
tein levels started already with the lowest concentration
of 50 μg/ml, stronger effects were seen at 100 μg/ml,
and maximal effects were achieved at 200 μg/ml as com-
pared to 300 μg/ml as shown in Fig. 3b. However, RBE
did not significantly alter the expression of COX-2 (only
a marginal increase observed) and mPGES-1 under non-
Fig. 2 RBE inhibits the release of 8-isoprostane (8-iso-PGF2α) in LPS-activated microglia. Microglia cells were pre-treated with RBE (10–300 μg/ml)
for 24 h; thereafter, cells were incubated with or without LPS (10 ng/ml) for the next 24 h. At the end of incubation, cell supernatants were
collected and release of 8-iso-PGF2α was measured by EIA. Statistical analysis was carried out by using one-way ANOVA with post hoc Student-
Newman-Keuls test (multiple comparisons). Results are expressed as means ± SEM of three independent experiments. *p < 0.05 compared with
LPS (10 ng/ml)-activated cells
Fig. 3 Effects of RBE on protein levels of COX-2 and mPGES-1 in LPS-activated microglia. Cells were pre-treated with RBE (50–300 μg/ml) for 24 h
followed by incubation of cells with or without LPS (10 ng/ml) for the next 24 h. Whole cell lysates were subjected to western blot for COX-2 and
mPGES-1. Representative blots for COX-2 and mPGES-1 are shown (a, b, upper panel) and densitometric analyses were performed (a, b, lower
panel). To confirm equal sample loading, membranes were stripped and reprobed for β-actin and the data were used for normalization. Statistical
analyses were carried out by using one-way ANOVA with post hoc Student-Newman-Keuls test (multiple comparisons). Results are expressed as
means ± SEM of three to five independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 compared with LPS (10 ng/ml)-activated cells
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and Additional file 3: Figure S3 (B)). These data suggest
that reduction in the release of PGE2 by RBE is due to
decreased expression of COX-2 and mPGES-1.
Inhibition of p38 MAPK, ERK1/2, and JNK activation
contributes to the anti-inflammatory effects of RBE
The role of MAPKs in neuroinflammation and Alzhei-
mer’s disease is well evident [21, 42, 43]. The major
MAPK pathway subfamilies involved in the regulation of
COX-2/mPGES-1 and cytokine synthesis in LPS-
activated microglia are signaling proteins such as extra-
cellular signal-regulated kinases (ERK1/2) or (p44/42
MAPK), JNK, and p38 MAPK. Therefore, we studied the
possible effects of RBE on the phosphorylation of these
kinases in primary rat microglia. As a result, pre-
incubation of RBE for 24 h has differential effects on the
phosphorylation of p38, ERK1/2, and JNK in LPS
(10 ng/ml)-activated microglia. Interestingly, reduction
in the phosphorylation of p38 with RBE was achieved as
low as with 50 μg/ml (~35 %, p < 0.05), which was fur-
ther reduced (~60 %, p < 0.01) with higher concentra-
tions (RBE 100 and 200 μg/ml). The phosphorylated
levels remained significantly low with the highest con-
centration of RBE (300 μg/ml), (~40 %, p < 0.05) as
shown in Fig. 4aFig. 4 Effects of RBE on the activation of p38 MAPK and ERK 1/2 MAPK. Ce
stimulation with or without LPS (10 ng/ml) for 30 min. Whole cell lysates w
panel) and densitometry analyses (lower panel) are shown a p38 MAPK and
ANOVA with post hoc Student-Newman-Keuls test (multiple comparisons).
experiments. *p < 0.05; **p < 0.01; ***p < 0.001 compared with LPS (10 ng/mAs shown in Fig. 4a, significant reduction of pERK
(~50 %, p < 0.05) was only achieved with the highest
concentration of RBE (300 μg/ml). However, only a
tendency towards decrease was observed with lower
concentrations but did not reach a significant statis-
tical value (Fig. 4b). Furthermore, RBE (200 μg/ml)
exerted inhibition of ~40 % (p < 0.05) and RBE
(300 μg/ml) ~60 % (p < 0.001) of the activation of JNK
in microglia (Fig. 5a). Furthermore, we also studied if
RBE itself has any significant influence on the phosphoryl-
ation of the abovementioned kinases. Similarly, RBE did
not alter the phosphorylation of p38MAPK, ERK (only
marginal increase but not significant), and JNK under
non-activated state of microglia (Additional file 4:
Figure S4 (A-C)).
Anti-inflammatory effects of RBE were independent of
IkB-α degradation
One of the first responses of the microglia to LPS stimu-
lation is the phosphorylation and degradation of IkB. In
resting cells, NF-kB is sequestered in the cytoplasm by
the inhibitory IkB protein. When activated by a stimulus,
such as LPS, IkB is phosphorylated by IKK. Phosphory-
lated IkB then undergoes ubiquitination and degradation
[44] and allows the NF-kB to translocate to the nucleus
and thereby facilitates the transcription of various pro-lls were pre-treated with RBE (50–300 μg/ml) for 24 h followed by
ere subjected to western blots analyses. Representative blots (upper
b ERK 1/2. Statistical analyses were carried out by using one-way
Results are expressed as means ± SEM of three to four independent
l)-activated cells
Fig. 5 Effects of RBE on the activation of JNK and degradation of IkB-α induced by LPS. Cells were pre-treated with RBE (50–300 μg/ml) for 24 h
followed by stimulation with or without LPS (10 ng/ml) for 30 min (for phospho-JNK) and 15 min (for IkB-α). Whole cell lysates were subjected to
western blots analyses. Representative blots (upper panel) and densitometry analyses (lower panel) are shown a pJNK and b IkB-α. Statistical analyses
were carried out by using one-way ANOVA with post hoc Student-Newman-Keuls test (multiple comparisons). Results are expressed as
means ± SE of three three to four independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 compared with LPS (10 ng/ml)-activated cells
or control cells (for IkB-α graph)
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dicator of NF-kB activation [35, 45]. Therefore, we also
studied the effects of RBE on the degradation of IkB-α.
Stimulation of LPS (10 ng/ml) for 15 min led to the deg-
radation of IkB-α while pre-incubation of RBE for 24 h
failed to reverse this effect (Fig. 5b), suggesting that the
regulatory effects of RBE on microglia activation are
confined to the MAPK pathway.
Effects of RBE on the LPS-mediated synthesis of pro-
inflammatory and anti-inflammatory cytokines
We furthermore tested whether the effects of RBE were
confined to the reduction of PGE2 and isoprostane re-
lease or if they also affect other inflammatory molecules.
To this end, we studied the effects of RBE on the gene
expression as well as release of pro-inflammatory cyto-
kines (TNF-α, IL-1β, and IL-6). These cytokines are
known to be important mediators of microglia inflam-
mation [35]. Stimulation of microglia cells with LPS
(10 ng/ml) for 4 h led to a significant increase in nor-
malized expression of TNF-α (LPS, 1.75 ± 0.21 vs. con-
trol, 0.005 ± 0.0005, p < 0.001), IL-1β (LPS, 1.31 ± 0.067
vs. control, 0.003 ± 0.0007, p < 0.001), and IL-6 (LPS
0.91 ± 0.09 vs. control 0.0 ± 0.0, p < 0.001) as shown in
Fig. 6a–c. Pre-treatment of RBE for 24 h significantly re-
duced the expression of TNF-α and IL-1β but failed toimpart any effect on the expression of IL-6 (Fig. 6c).
Mild reduction in the expression of TNF-α started at
100 μg/ml of RBE (77.07 ± 4.96 %, p < 0.05), moderate at
200 μg/ml (62.27 ± 6.59 %, p < 0.01) and achieved max-
imal effects at 300 μg/ml (46.31 ± 3.96 %, p < 0.001) as
depicted in Fig. 6a. Pre-treatment of RBE (50 and
100 μg/ml) did not show any significant modulatory ef-
fects on the expression of IL-1β (Fig. 6b). However, with
the higher concentrations of RBE (200 and 300 μg/ml), a
significant decrease of ~25 % (p < 0.05) was observed as
compared with LPS 10 ng/ml (taken as 100 %). Further-
more, in case of release of cytokines, 24-h stimulation of
microglia with LPS (10 ng/ml) leads to a significant up-
regulation of TNF-α (control, 7.71 ± 2.57 pg/ml vs. LPS,
1401 ± 130 pg/ml), IL-6 (control, 52.73 ± 2.64 pg/ml vs.
LPS, 1086 ± 88.40 pg/ml), and IL-1β (control, 1.35 ±
1.35 pg/ml vs. LPS + ATP, 316.8 ± 87.01 pg/ml). Simi-
larly, cells with the prior treatment of RBE had less
levels of TNF-α and IL-1β whereas levels of IL-6 did not
alter significantly as shown in Fig. 7a–c. Of note, in case
of IL-1β release, addition of ATP (30 min prior to collec-
tion of supernatants from culture wells) was important
since release of IL-1β is dependent on the ICE/caspase
1. ATP via the P2X7 receptor acts as extracellular trigger
for ICE/caspase 1 activation. Therefore, we did not see
any significant changes in the extracellular accumulation
Fig. 6 Effects of RBE on the gene expression of TNF-α, IL-1β, IL-6, and IL-10 in LPS-activated microglia. Cells were pre-treated with RBE (50–300 μg/ml)
for 24 h followed by stimulation with or without LPS (10 ng/ml) for 4 h. Afterwards, gene expression of a TNF-α, b IL-1β, c IL-6, and d IL-10 was
analyzed by real-time quantitative PCR. GAPDH was used as an internal control for normalization and data were quantified by using
comparative cycle threshold Ct method. Data are presented as percentage control of LPS. Results are expressed as means ± SEM of three
to five independent experiments. Statistical analyses were carried out by using one-way ANOVA with post hoc Student-Newman-Keuls test
(multiple comparisons). *p < 0.05; **p < 0.01; ***p < 0.001 compared with LPS (10 ng/ml)-activated cells
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ATP (data not shown in the graph). All of these above
data suggest specific effects of RBE (at various threshold
concentrations) on distinct inflammatory mediators in
microglia. In order to understand if RBE has any modula-
tory effects on the polarity of microglia (M1, pro-
inflammatory vs. M2, anti-inflammatory), gene expression
of the well-accepted M2 cytokine (IL-10) was studied
using real-time PCR. In contrast to pro-inflammatory
cytokines, treatment of RBE led to further augmentation
of IL-10 gene expression starting from RBE 50 μg/ml
(176.7 ± 17.07 %, p < 0.01), at RBE 100 μg/ml (170.3 ±
16.36 %, p < 0.01), at RBE 200 μg/ml (183.9 ± 18.79 %,
p < 0.01), and reached a maximum at RBE 300 μg/ml
(229.5 ± 23.22 %, p < 0.001) as shown in Fig. 6d. These
data indicate that RBE might be involved in polarizing
microglia by influencing the expression of pro- and
anti-inflammatory cytokines. Additionally, to seek the
experimental evidences if these beneficial effects of
RBE in microglia can be mimicked by α-tocopherol
(one of the active components of RBE), various assayshave been performed. Briefly, experiments were per-
formed with α-tocopherol (10–100 μM) in a similar
manner as of RBE to see if α-tocopherol can mimic all
or some of the data we got with RBE treatment. Inter-
estingly, we did not observe any significant changes in
the levels of PGE2, TNF-α, IL-1β, and IL-6 (see
Additional file 5: Figure S5 (A-D)). These data indicates
that effects mediated by RBE in microglia cannot be ex-
plained by the α-tocopherol alone.
Discussion
In this study, we demonstrate that RBE inhibits micro-
glia activation by suppressing the production of PGE2
and 8-iso-PGF2α—a marker for free radical production.
RBE exhibited further beneficial effects by reducing pro-
inflammatory cytokines (TNF-α and IL-1β). In addition,
pre-stimulation with RBE for 24 h enhanced the expres-
sion levels of anti-inflammatory (IL-10) cytokine in LPS-
stimulated rat microglia. Furthermore, we were also able
to dissect the underlying signaling mechanism/s by
which RBE imparted its beneficial effects, schematically
Fig. 7 Effects of RBE on the release of TNF-α, IL-1β, and IL-6 in LPS-activated microglia. Cells were pre-treated with RBE (50–300 μg/ml) followed
by stimulation with or without LPS (10 ng/ml) for 24 h. Afterwards, release of a TNF-α, b IL-1β, and c IL-6 was analyzed by ELISA. Data are presented as
percentage control of LPS. Results are expressed as means ± SEM of three to four independent experiments. Statistical analyses were carried out by
using one-way ANOVA with post hoc Student-Newman-Keuls test (multiple comparisons). *p < 0.05; **p < 0.01; ***p < 0.001 compared with LPS
(10 ng/ml)-activated cells
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is the very first evidence for the anti-inflammatory ef-
fects of RBE in the immune cells of CNS. Immunomod-
ulatory effects of rice bran (black and brown) extract in
the peripheral nervous system (PNS) of CD-1 mice have
previously been explored [46]. This study showed the
anti-inflammatory activities of black rice bran (10 mg/kg
body weight) in a topical application of TPA (12-O-tetra-
decanolylphorbol-13-acetate)-induced skin edema. Anti-
inflammatory actions exerted by black rice bran in this
study were due to the suppression of TNF-α, IL-6, and
IL-1β leaving PGE2 production unchanged, whereas
brown rice bran extract had no effect on studied mole-
cules. This study is in contrast to ours, at least in part,
where we showed significant downregulation of PGE2
without affecting the IL-6 production. This inconsistency
in studies might be explained due to the different study
models (CNS vs. PNS; in vitro vs. in vivo). Another ex-
planation might lie in the different composition andstability of RBE due to the distinct extraction methods.
We observed that RBE did not reduce the survival of
microglial cells either alone or in combination with LPS.
More interestingly, RBE further elevated the levels of
ATP under basal as well as in stimulated conditions.
These findings are in agreement with the previous find-
ings where the authors showed the beneficial effects of
RBE on mitochondrial dysfunction. These activities of
RBE were attributed to restoring mitochondrial en-
dogenous respiration and ATP contents [31, 32]. One
can speculate that restoration of mitochondrial function
by RBE was owing to its anti-inflammatory and anti-
oxidant features. There are few evidences showing that
mitochondrial function may require a multifaceted ap-
proach that includes drugs and plant-derived phenolic
compounds with anti-oxidant and anti-inflammatory ac-
tivities [47]. It is not precisely clear if such correlation
exists in our model, and we believe that this is intriguing
and worth exploring in our future studies. Another
Fig. 8 Schematic showing the effects of RBE on LPS-activated microglia. Stimulation of Toll-like receptor (TLR)-4 by LPS resulted in a phosphorylation
and thus activation of mitogen-activated protein kinases (MAPK) signal cascade as well as NF-kB pathway. RBE exerted its beneficial effects by interfering
in the activation of key kinases in MAPK signaling cascade but failed to affect NF-kB pathway. These effects of RBE were corroborated by reduction in the
levels of COX-2/mPGES-1 and hence PGE2 production. RBE also imparted its anti-inflammatory effects by reducing the expression of pro-inflammatory
cytokines (M1 markers; IL-1β and TNF-α) and by counterbalancing the levels of anti-inflammatory cytokine (M2 marker; IL-10) in microglia. Moreover, these
beneficial effects of RBE are possibly due to, at least in part, by reduction in free radical formation (8-isoprostane) in microglia
Bhatia et al. Journal of Neuroinflammation  (2016) 13:148 Page 12 of 16reason for the increase in ATP levels might be due to an
enhancement in the proliferation of microglia after RBE
treatment. To find this out, we performed cell cycle ana-
lysis. As a result, we did observe a tendency towards an
enhancement of microglial proliferation with RBE but it
did not reach to a significant statistical value. Thus, we
believe that this enhancement in proliferation might
have contributed towards enhanced levels of ATP as
shown in viability assay but we cannot rule out other
factors, which warrant further assessment. Moreover, to
the best of our knowledge, there is no such study inves-
tigating the proliferation after RBE treatment in the
brain (in vivo) or in glial cell cultures. Though in con-
trast, there are previous studies showing the anti-
proliferative actions of rice bran or RBE in cancerouscell lines. For example, water-soluble enzymatic extract
from rice bran (EERB) imparted its anti-proliferative ef-
fects in human T cell acute lymphoblastic leukemia
(MOLT-4) [48]. Another study by a Japanese group
showed the immunomodulatory and anti-proliferative ef-
fects of various rice bran extracts (red, black, brown) in
culture immunocompetent cells [49]. All of these studies
have various experimental differences in comparison
with our study. These studies were done with much
higher concentrations of RBE (e.g., 300 μg/ml vs. 10 mg/
ml); another differences were primary cell cultures vs.
cell lines and differences in the variety of rice bran and
preparation of extract. If we look at the effects of vita-
min E congeners (tocopherols and tocotrienols) on the
proliferation, there are ample evidences proving the pro-
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tocotrienols induce lymphocyte proliferation, and the
study by Flanary and Streit showed that α-tocopherol in-
duces proliferation in cultured rat microglia [38, 50].
Thus, in our study, this enhancement of proliferation of
microglia might have come through tocopherol or toco-
trienols or via synergistic effects of both.
Next, we examined the effects of RBE on the forma-
tion of 8-iso-PGF2α—an index of oxidative stress-
mediated production of lipid hydroperoxides. In post-
mortem brains of AD patients, levels of F2-isoprostane
have been shown to be elevated [51, 52]. Earlier, we have
demonstrated the ability of natural products to inhibit
the 8-iso-PGF2α in activated microglia [41, 53]. Similarly,
our current findings with RBE show that the extract af-
fects the formation of free radicals in microglia, confirm-
ing the anti-oxidant properties of this extract.
The COX-2/mPGES-1 enzyme pathway and subse-
quent generation of prostaglandins play a significant role
in microglia activation. mPGES-1 is the terminal enzyme
for the biosynthesis of PGE2 during inflammation and is
normally functionally coupled with COX-2 with few ex-
ceptions [18]. This enzyme is markedly induced by pro-
inflammatory stimuli and is downregulated by anti-
inflammatory glucocorticoids. In order to gain a better
understanding of the mechanism of action of RBE, we
investigated its effect on COX-2 and mPGES-1 protein
levels in LPS-treated microglia. Our data show that RBE
inhibited COX-2 and mPGES-1 after 24 h of LPS stimu-
lation, suggesting that RBE acts to reduce PGE2 produc-
tion by interfering with both COX-2 and mPGES-1
protein synthesis in LPS-activated microglia. Previously,
the stabilized RBE has shown to inhibit the activity of
COX-2 enzyme in a cell-free system [54]. In this study,
an effect of RBE on the mPGES-1 was not studied, sug-
gesting the novelty of our work.
MAPK are involved in the regulation of inflammatory
events. For instance, activation of ERK and p38 MAPK
are implicated in the regulation of COX-2 expression in
activated microglia [15, 55]. Moreover, our group has
previously shown the involvement of ERK and p38
MAPK in the induction of mPGES-1 in rat microglia
[18]. In this study, a common involvement of JNK has
also been reported in the regulation of both COX-2 and
mPGES-1 expression. In our present study, RBE exerted
strong suppressive effects on the phosphorylation of p38
and JNK following LPS induction. However, in case of
pERK, only modest inhibitory effects were seen with the
highest concentration of RBE (300 μg/ml). Differential
regulation of these proteins at various threshold concen-
trations of RBE indicates specificity of its ingredients for
certain proteins. For instance, at the same time, one of
the ingredients has inhibitory effects on certain protein
while enhancing effect on others.NF-kB activation has been linked to neurotoxicity
through production of pro-inflammatory molecules in
glial cells, suggesting its role in neurodegenerative con-
ditions [56]. We therefore determined if RBE exhibited
its anti-inflammatory effects via the suppression of NF-
kB activation. The inflammatory responses to NF-kB are
negatively regulated by its inhibitory subunit IkB-α [57].
In the current study, we found that LPS treatment re-
duced IkB-α levels in microglia as compared to un-
treated cells while pre-incubation of RBE for 24 h did
not affect IkB-α degradation. However, the fact that
RBE did not affect LPS-induced IkB-α degradation
suggests that reduced expression of COX-2 and
mPGES-1 by RBE is independent of NF-kB activation.
Most recently, the bioavailability of RBE components
in the brains of Guinea pigs and aged NMRI mice
were examined [31, 58]. Apart from this there are—to
the best of our knowledge—no more publications
about bioavailability of RBE ingredients after administra-
tion of RBE. Briefly, they found that α-tocopherol was the
most abundant vitamin E derivative found in Guinea pig
brains, followed by α-tocotrienol and γ-tocotrienol.
Another study was performed in NMRI—one of the well-
established models of senescence. Similarly, only α-
tocopherol could be detected in brain homogenates of
young and aged mice and concentrations of all other
tocopherol and tocotrienol derivatives were below the
limit of detection. Therefore, to seek the experimental
evidences if these effects imparted by RBE can be mim-
icked by α-tocopherol, we performed various assays
with α-tocopherol. Interestingly, we did not observe
any significant changes in the levels of PGE2, TNF-α,
IL-1, and IL-6 (see Additional file 5: Figure S5 (A-D)).
These data indicates that effects mediated by RBE in
microglia cannot be explained by the α-tocopherol
alone. RBE is a complex blend of known as well as still
unknown compounds. Thus, we think that components
other than α-tocopherols might have exerted their ef-
fects in regulating microglial activation. Previously, it
was shown that only vitamin E from natural sources
like RBE (mixture of eight vitamin E congeners) was
able to protect brain against neurodegeneration [23,
59]. Accordingly, we can hypothesize that α-tocopherol
is not the only active component present in RBE;
others, most importantly tocotrienols, may have also
contributed towards the downregulation of microglial
activation. Also, one cannot rule out the effects of poly-
unsaturated fatty acids (PUFA) such as alpha-linolenic
acid, which is also present in RBE. Studies on diets and
drugs targeting PUFA have been emerging as disease-
modifying agents [60]. We believe that our present
study provides the fundamental knowledge (for us and
others) of effects of RBE in regulating microglial func-
tion. Thus, a more elaborated characterization of RBE
Bhatia et al. Journal of Neuroinflammation  (2016) 13:148 Page 14 of 16contents and its accumulation in the brain is required
to identify the function of particular active compound.Conclusions
Altogether, our data provided the evidence that in acti-
vated microglia, RBE exerts beneficial effects by targeting
COX-2/mPGES-1 in PGE2 production as well as by
modulating cytokine levels. These beneficial effects are
possibly due to, at least in part, anti-oxidant features of
the extract. The underlying mechanism of action by which
RBE exerted its anti-inflammatory effects was mainly
dependent on MAPKs pathway without affecting NF-kB
signaling. Thus, RBE represents the potential to regulate
microglia activation (in vitro) and must be further investi-
gated in animal models of neuroinflammation.Additional files
Additional file 1: Figure S1. (A-K). Possible effects of rice bran extract
(RBE) on the proliferation of microglia. Microglia were treated with either
RBE (300 μg/ml) alone or RBE (50–300 μg/ml) in combination with LPS
(10 ng/ml) for a total of 48 h. Thereafter, samples were stained with
propidium iodide and processed for proliferation assay (for detailed
protocol, see the “Methods” section) by using flow cytometer. Samples
were acquired with the FL-2 fluorescence channel set to a linear scale, in
order to amplify the diploid DNA peak. Graph A) represents the dot plot
of cells acquired on the basis of side scattered light (SSC) and forward
scattered light (FSC) and B) represents the pulse processing by using
pulse area vs. pulse width. Graphs C-I) are representative histograms after
each treatment. Markers represent the percentage of cells in the G0/G1,
S, and G2/M phases from left to right, respectively. J) Represents
histogram after 48 h treatment of M-CSF (50 ng/ml) used as positive
control for proliferation. K) Showing quantification of microglial cells in
each phase of cell cycle after respective treatments. Data are presented
in percentage of cells in each phase. Results are expressed as means ±
SEM of three independent experiments. Statistical analyses were carried
out by using one-way ANOVA with post hoc Student-Newman-Keuls test
(multiple comparisons). *p < 0.05; compared with percentage of control
cells in each phase. (TIF 536 kb)
Additional file 2: Figure S2. RBE did not significantly alter the protein
levels of COX-2 in non-stimulated microglia. Cells were treated with RBE
(50–300 μg/ml) for 24 h followed by lyses and protein estimation. During
stimulation of microglia, one well of the 6-well plate was incubated with
LPS (10 ng/ml) for 24 h to be used as positive control to validate the
functionality of COX-2-specific antibody. Whole cell lysates were
subjected to western blot for COX-2 and β-actin. Representative blots for
COX-2 and β-actin are shown (upper panel) and densitometry analyses
were performed (lower panel). To confirm equal sample loading,
membranes were stripped and re-probed for β-actin and the data were
used for normalization. Statistical analyses were carried out by using
one-way ANOVA with post hoc Student-Newman-Keuls test (multiple
comparisons). Results are expressed as means ± SEM of three independent
experiments. ***p < 0.001 compared with control cells. (TIF 323 kb)
Additional file 3: Figure S3. (A-F). Possible influence of RBE alone on
the expression of various genes. Cells were treated with RBE (50–300 μg/ml)
for 24 h. LPS (10 ng/ml) was used in one of the wells as positive control to
validate the functionality of primers and PCR protocol. Afterwards, gene
expression of A) COX-2, B) mPGES-1, C) TNF-α, D) IL-1β, E) IL-6, and F) IL-10
was analyzed by real-time quantitative PCR. GAPDH was used as an internal
control for normalization, and data were quantified by using comparative
cycle threshold Ct method. Data are presented as percentage control of LPS.
Results are expressed as means ± SEM of three independent experiments.
Statistical analyses were carried out by using one-way ANOVA with post hocStudent-Newman-Keuls test (multiple comparisons). ***p < 0.001 compared
with LPS (10 ng/ml)-activated cells. (TIF 585 kb)
Additional file 4: Figure S4. (A-C). Effects of RBE on the
phosphorylation of p38MAPK, ERK, and JNK in non-activated microglia.
Cells were treated with RBE (50–300 μg/ml) for 24 h followed by cell lyses
and protein estimation. During stimulation, one of the wells in 6-well
plate was incubated with LPS (10 ng/ml) for 30 min to be used as
positive control to validate the functionality of antibodies against
activated state of kinases. Whole cell lysates were subjected to western
blots analyses. Representative blots (upper panel) and densitometry
analyses (lower panel) are shown: A) p38 MAPK, B) pERK, and C) pJNK.
Statistical analyses were carried out by using one-way ANOVA with post
hoc Student-Newman-Keuls test (multiple comparisons). Results are
expressed as means ± SEM of three independent experiments. *p < 0.05;
**p < 0.01; ***p < 0.001 compared control cells. (TIF 963 kb)
Additional file 5: Figure S5. (A-D). Effects of α-tocopherol on the
release of PGE2 and cytokines. Influence of α-tocopherol on the release of
PGE2, TNF-α, IL-1β, and IL-6 in LPS-activated microglia was also examined.
Cells were pre-treated with RBE (50–300 μg/ml); subsequently, LPS
(10 ng/ml) was added for 24 h. Afterwards, release of A) PGE2, B) TNF-α,
C) IL-1β, and D) IL-6, was analyzed by using immunoassays. Data are
presented as percentage control of LPS. Results are expressed as means
± SEM of three to four independent experiments. Statistical analyses were
carried out by using one-way ANOVA with post hoc Student-Newman-
Keuls test (multiple comparisons). *p < 0.05; **p < 0.01; ***p < 0.001
compared with LPS (10 ng/ml)-activated cells. (TIF 685 kb)
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